CN113925901A - 一种治疗鼻窦炎的精油组合物及其制备方法 - Google Patents
一种治疗鼻窦炎的精油组合物及其制备方法 Download PDFInfo
- Publication number
- CN113925901A CN113925901A CN202111463776.3A CN202111463776A CN113925901A CN 113925901 A CN113925901 A CN 113925901A CN 202111463776 A CN202111463776 A CN 202111463776A CN 113925901 A CN113925901 A CN 113925901A
- Authority
- CN
- China
- Prior art keywords
- parts
- essential oil
- oil composition
- oil
- catechu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 71
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003921 oil Substances 0.000 claims abstract description 50
- 240000005125 Myrtus communis Species 0.000 claims abstract description 27
- 235000013418 Myrtus communis Nutrition 0.000 claims abstract description 27
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 23
- 244000235603 Acacia catechu Species 0.000 claims abstract description 23
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 23
- 241000928504 Centipeda minima Species 0.000 claims abstract description 23
- 241000218378 Magnolia Species 0.000 claims abstract description 23
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 23
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 23
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 23
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 22
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 22
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 19
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940116229 borneol Drugs 0.000 claims abstract description 19
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 18
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 18
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 18
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 18
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 9
- 210000003928 nasal cavity Anatomy 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 201000009890 sinusitis Diseases 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000004537 pulping Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 12
- 208000002193 Pain Diseases 0.000 abstract description 9
- 206010039101 Rhinorrhoea Diseases 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 8
- 208000010753 nasal discharge Diseases 0.000 abstract description 6
- 210000002850 nasal mucosa Anatomy 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 206010041232 sneezing Diseases 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 230000003266 anti-allergic effect Effects 0.000 abstract description 4
- 208000010668 atopic eczema Diseases 0.000 abstract description 4
- 206010052437 Nasal discomfort Diseases 0.000 abstract description 3
- 230000000172 allergic effect Effects 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 3
- 230000017423 tissue regeneration Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 235000008216 herbs Nutrition 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 206010028748 Nasal obstruction Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000004877 mucosa Anatomy 0.000 description 5
- 210000003097 mucus Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 210000003695 paranasal sinus Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 206010039083 rhinitis Diseases 0.000 description 4
- 208000004371 toothache Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000420 mucociliary effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 206010049153 Allergic sinusitis Diseases 0.000 description 2
- 240000000572 Blumea balsamifera Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000036071 Rhinorrhea Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 208000027744 congestion Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 1
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000264877 Hippospongia communis Species 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000001705 Mouth breathing Diseases 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 206010028741 Nasal inflammation Diseases 0.000 description 1
- 206010028779 Nasal turbinate hypertrophy Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039088 Rhinitis atrophic Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000001180 ethmoid sinus Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002454 frontal bone Anatomy 0.000 description 1
- 210000001214 frontal sinus Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 210000004086 maxillary sinus Anatomy 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000016366 nasal cavity polyp Diseases 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 210000000492 nasalseptum Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000002474 sphenoid bone Anatomy 0.000 description 1
- 210000003718 sphenoid sinus Anatomy 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗鼻窦炎的精油组合物及其制备方法,包括如下原料:桃金娘油、辛夷花油、薄荷精油、冰片、鹅不食草、白芷、儿茶、川芎、栀子,以及羟丙基甲基纤维素。原料均从植物中进行提取,不添加任何人工合成成分,安全无毒副作用,且针对鼻窦炎,能够充分杀菌、抑菌,止痛生肌,可减轻并修复鼻黏膜充血、改善鼻痒、喷嚏、流清水样鼻涕等症状,同时能够充分缓解过敏症状,具有抗过敏功效。所述制备方法仅需将原料均匀混合即可,方法简单、工艺易控,可规模化进行生产。
Description
技术领域
本发明属于药物领域,具体涉及一种治疗鼻窦炎的精油组合物及其制备方法。
背景技术
鼻炎指固有鼻腔里的黏膜发生炎症。而鼻窦炎与鼻炎发生炎症的部位不一样。鼻窦是固有鼻腔周围有四个蜂房一样含气骨性结构:上颌窦位于鼻腔两旁、眼眶下面的上颌骨内;额窦在额骨内;筛窦位于鼻腔上部的两侧,由筛管内许多含气小腔组成;蝶窦在鼻腔后方的蝶骨内。因此,鼻窦炎指鼻窦黏膜发生炎症。窦的黏膜都与鼻黏膜相连,因而鼻腔黏膜发炎,如不及时治疗,常会波及窦腔黏膜,发生炎症。鼻甲肥大、鼻中隔弯曲、鼻息肉和因伤风感冒或受邻近病灶感染而使鼻黏膜发炎肿胀时,都可能造成鼻腔内的机械性障碍,使鼻窦开口受阻,引流不畅,造成鼻窦发炎;不正确的擤鼻涕方法会使鼻腔压力增加,使鼻涕回流到鼻窦而引起鼻窦炎症。
鼻窦炎与鼻炎相比,由于发生的位置更加深入,所以外用药不易达到患处。而现有治疗鼻窦炎多采用口服西药或中药,但“是药三分毒”,很多药物会增加肾脏负担,经常用药会带来不良的副作用。
精油又称挥发油,广泛存在于多种植物中,具有天然活性成分,不添加任何人工合成成分,安全无毒副作用。本发明人运用中医理论,选取合适的精油成分进行复配,克服了现有技术中的上述缺陷,有效治疗了鼻窦炎。
发明内容
为了解决现有技术存在的问题,本发明提供了一种治疗鼻窦炎的精油组合物及其制备方法。所述治疗鼻窦炎的精油组合物均从植物中进行提取,不添加任何人工合成成分,安全无毒副作用,且针对鼻窦炎,能够充分杀菌、抑菌,止痛生肌,可减轻并修复鼻黏膜充血、改善鼻痒、喷嚏、流清水样鼻涕等症状,同时能够充分缓解过敏症状,具有抗过敏功效。所述制备方法仅需将原料均匀混合即可,方法简单、工艺易控,可规模化进行生产。
本发明的方案是,提供一种治疗鼻窦炎的精油组合物,包括如下原料:桃金娘油、辛夷花油、薄荷精油、冰片、鹅不食草、白芷、儿茶、川芎、栀子,以及辅料。
优选地,所述辅料为羟丙基甲基纤维素。
优选地,所述治疗鼻窦炎的精油组合物包括如下重量份的原料:桃金娘油30-35份、辛夷花油5-10份、薄荷精油3-5份、冰片1-2份、鹅不食草3-5份、白芷1-2份、儿茶3-5份、川芎1-2份、栀子1-2份,以及羟丙基甲基纤维素2-3份。
最佳地,所述治疗鼻窦炎的精油组合物包括如下重量份的原料:桃金娘油32份、辛夷花油8份、薄荷精油4份、冰片1.5份、鹅不食草4份、白芷1.5份、儿茶4份、川芎1.5份、栀子1.5份,以及羟丙基甲基纤维素2份。
本发明是以精油形式储存的,以桃金娘油、辛夷花油和薄荷精油的精油混合物为主要成分,加入冰片、白芷、羟丙基甲基纤维素的研磨粉以及鹅不食草、儿茶、川芎和栀子的中药提取液制备得到。
本发明提供一种治疗鼻窦炎的精油组合物的制备方法,其中,
(1)按重量份比称取桃金娘油、辛夷花油和薄荷精油,置于无菌反应釜中,灭菌处理;
(2)按重量份比称取冰片、白芷、羟丙基甲基纤维素,研磨,过筛网即得研磨粉;
(3)按重量份比称取鹅不食草、儿茶、川芎和栀子,投入反应釜中,加入蒸馏水浸泡一段时间,破壁打浆,煮沸后改用小火煎煮,滤出一次煎煮液,再次加入蒸馏水煎煮,煮沸后改用小火煎煮,滤出二次煎煮液;将一次、二次滤液混合均匀、冷却、过滤,取滤液,将滤液浓缩至所需重量,即得中药提取液;
(4)将(2)和(3)的产物混合均匀后灭菌处理;
(5)将(1)和(4)的产物混合,即得疗鼻窦炎的精油组合物。
优选地,步骤(2)过100目筛网。
优选地,步骤(3),按重量份比称取鹅不食草、儿茶、川芎和栀子,投入反应釜中,加入200份蒸馏水浸泡一段时间,破壁打浆,煮沸后改用小火煎煮30min,滤出一次煎煮液,再次加入100份蒸馏水煎煮,煮沸后改用小火煎煮30min,滤出二次煎煮液;将一次、二次滤液混合均匀、冷却、过滤,取滤液,将滤液浓缩至所需重量,即得中药提取液。
本发明还提供一种所述治疗鼻窦炎的精油组合物的使用方法:将精油组合物涂抹于鼻腔表面,外敷温热毛巾,至精油被完全吸收即可。
为便于对本发明的理解,下面对本发明的原料及作用做进一步阐述。
桃金娘油:桃金娘油可重建上、下呼吸道的粘液纤毛清除系统的清除功能,从而稀化和碱化粘液,增强粘液纤毛运动,粘液移动速度显著增加,促进痰液排出。此外,桃金娘油具有抗炎作用,能通过减轻支气管粘膜肿胀而起到舒张支气管的作用。桃金娘油对细菌和真菌亦具有杀菌作用。
辛夷花油:性温、味辛,归肺、胃经,具有祛风寒、通鼻窍的作用,主治:风寒头痛、鼻渊、鼻流浊涕、鼻塞不通、齿痛。
薄荷:薄荷为唇形科植物,即同属其他干燥全草,它是辛凉性发汗解热药,能够治流行性感冒、头疼、目赤、身热、咽喉、牙床肿痛等症。薄荷精油是薄荷经过水蒸馏或亚临界低温萃取出的成分,具有止咳平喘、清热解毒、祛风止疼之功效,可用于治疗流行性感冒、头疼、神经痛等症状。
冰片:菊科植物艾纳香Blumea balsamifera.DC.的叶中提取物中结晶,习称“艾片”。性寒,味辛、苦。归心经、脾经、肺经。具有开窍醒神、清热止痛的作用。属开窍药。
鹅不食草:菊科植物石胡荽Centipeda minima(L.)A.Braun e tAschers.的全草。具有发散风寒,通鼻窍,止咳,解毒的功效。主治风寒感冒,鼻塞不通,寒痰咳喘,疮痈肿毒。
白芷:性温,味辛。归胃经、大肠经、肺经。常用于散风除湿、通窍止痛、消肿排脓。属解表药下属分类的辛温解表药。
儿茶:具有活血止痛,止血生肌,收湿敛疮,清肺化痰的功效。用于跌扑伤痛,外伤出血,吐血衄血,疮疡不敛,湿疹、湿疮,肺热咳嗽。
川芎:性温,味辛。归肝经、胆经、心包经。具有活血行气,祛风止痛的功效。属活血化瘀药下属分类的活血止痛药。
栀子:性寒,味苦。归心经、肺经、三焦经。具有泻火除烦、清热利尿、凉血解毒的功效;外用消肿止痛。属清热药分类下的清热泻火药。
羟丙基甲纤维素:常见中药辅料。
本发明以桃金娘油、辛夷花油、薄荷精油为主,利用桃金娘油对于呼吸道中粘液纤毛的增强作用,促进痰液排出,同时这也是促进了鼻窦内的微循环,且桃金娘油具有消炎作用,对于细菌和真菌的杀菌作用明显。辛夷花油和薄荷精油对于通窍和缓解鼻窦炎所带来的头痛、牙痛等并发症作用显著。其次利用、冰片、鹅不食草、白芷和栀子的清热解毒、通窍功效,川芎具有活血行气之功效,儿茶常用于治疗外伤,然而发明人发现儿茶与川芎再与上述组分混合之后,治疗鼻窦炎的功效具有显著提升。现有技术(如CN101224276A)会认为儿茶等收涩、渗湿,需要制成膏剂或粉剂,外用于鼻腔后,会出现较多黄色或清水样鼻涕,长期使用会对鼻腔粘液分泌腺以及细胞受到破坏,丧失分泌功能,从而导致鼻腔粘膜得不到正常的湿润,影响鼻腔的调温、加湿等功能,出现鼻腔干燥、同样,有冷气顶脑等感觉,如不及时治疗,甚至会导致萎缩性鼻炎。本发明将其用于精油混合液中,避免了上述问题,与川芎一起虽然作为辅助成分加入,显著提高了治疗鼻炎的效果。
综上所述,原料配伍科学,作用相互协同,缺一不可,且针对鼻窦炎,能够充分杀菌、抑菌,止痛生肌,可减轻并修复鼻黏膜充血、改善鼻痒、喷嚏、流清水样鼻涕等症状,同时能够充分缓解过敏症状,具有抗过敏功效。
本发明所述的治疗治疗鼻窦炎的精油组合物的制备方法,仅需将原料均匀混合即可,方法简单、工艺易控,可规模化进行生产。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚,下面将对本发明的技术方案进行详细的描述。
实施例1
本实施例提供一种治疗鼻窦炎的精油组合物,重量份组成如下:桃金娘油30份、辛夷花油5份、薄荷精油3份、冰片1份、鹅不食草3份、白芷1份、儿茶3份、川芎1份、栀子1份,以及羟丙基甲基纤维素2份。
(1)按重量比称取桃金娘油、辛夷花油和薄荷精油,置于无菌反应釜中,灭菌处理;
(2)按重量份比称取冰片、白芷、羟丙基甲基纤维素,研磨,过100目筛网即得研磨粉;
(3)重量份比称取鹅不食草、儿茶、川芎和栀子,投入反应釜中,加入200份蒸馏水浸泡一段时间,破壁打浆,煮沸后改用小火煎煮30min,滤出一次煎煮液,再次加入100份蒸馏水煎煮,煮沸后改用小火煎煮30min,滤出二次煎煮液;将一次、二次滤液混合均匀、冷却、过滤,取滤液,将滤液浓缩至所需重量,即得中药提取液;
(4)将(2)和(3)的产物混合均匀后灭菌处理;
(5)将(1)和(4)的产物混合,即得疗鼻窦炎的精油组合物。
实施例2
本实施例提供一种治疗鼻窦炎的精油组合物,重量份组成如下:桃金娘油35份、辛夷花油10份、薄荷精油5份、冰片2份、鹅不食草5份、白芷2份、儿茶5份、川芎2份、栀子2份,以及羟丙基甲基纤维素3份。制备方法参照实施例1。
实施例3
本实施例提供一种治疗鼻窦炎的精油组合物,重量份组成如下:桃金娘油32份、辛夷花油8份、薄荷精油4份、冰片1.5份、鹅不食草4份、白芷1.5份、儿茶4份、川芎1.5份、栀子1.5份,以及羟丙基甲基纤维素2份。制备方法参照实施例1。
对比例1
一种治疗鼻窦炎的精油组合物,重量份组成如下:桃金娘油30份、辛夷花油5份、薄荷精油3份、冰片1份、鹅不食草3份、白芷1份、栀子1份,以及羟丙基甲基纤维素2份。制备方法参照实施例1。
对比例2
一种治疗鼻窦炎的精油组合物,重量份组成如下:桃金娘油30份、辛夷花油5份、薄荷精油3份、冰片1份、鹅不食草3份、白芷1份、儿茶3份、栀子1份,以及羟丙基甲基纤维素2份。制备方法参照实施例1。
对比例3:一种治疗鼻窦炎的精油组合物,重量份组成如下:桃金娘油30份、辛夷花油5份、薄荷精油3份、冰片1份、鹅不食草3份、白芷1份、川芎1份、栀子1份,以及羟丙基甲基纤维素2份。制备方法参照实施例1。
本发明的治疗鼻窦炎的精油组合物的使用效果观察:
患者资料:有医院确诊证明的鼻窦炎患者共计120例,其中男64例,女56例,年龄在24-40岁之间。
随机分配,30名患者采用实施例1制备的精油组合物,30名患者采用对比例1制备的精油组合物,30名患者采用对比例2制备的精油组合物,30名患者采用对比例3制备的精油组合物。
使用方法:将精油组合物以鼻喷剂的形式,每次向鼻腔中喷入0.2mL精油组合物,每天早中晚各一次,坚持使用3个疗程,1个疗程为4周。
结果如下:
典型案例
病例1:
王某,女,38岁;患鼻窦炎12年;工作紧张压力大,经常熬夜,喜好辛辣食品,鼻窦炎反复发作,喷嚏不断,鼻塞,粘稠鼻涕,长期偏头痛。虽长期服用抗过敏药,但是没有解决根本性问题,鼻窦炎反复发作,久治不愈。后使用本发明所述治疗鼻窦炎的精油组合物,鼻窦炎逐步康复,且体质有所增强,目前仍在持续使用中。
病例2:
李某,男,21岁;患过敏性鼻窦炎3年;每年秋季病情加重,鼻塞严重、鼻涕较多,口呼吸严重。后使用本发明所述治疗鼻窦炎的精油组合物,整个冬季没有出现鼻塞、流涕现象。
病例3:
贾某,男,29岁;患过敏性鼻窦炎8年;流清鼻涕,不定时打喷嚏,鼻腔充血发痒,发作时伴有头痛牙痛症状。后采用发明所述治疗鼻窦炎的精油组合物1个疗程,效果显著,喷嚏明显减少,鼻腔分泌物减少,头痛和牙痛症状消失。
综上可见,本发明的精油组合物治疗鼻窦炎效果显著。
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应以所述权利要求的保护范围为准。
Claims (7)
1.一种治疗鼻窦炎的精油组合物,包括如下原料:桃金娘油、辛夷花油、薄荷精油、冰片、鹅不食草、白芷、儿茶、川芎、栀子,以及羟丙基甲基纤维素。
2.根据权利要求1所述的精油组合物,包括如下重量份的原料:桃金娘油30-35份、辛夷花油5-10份、薄荷精油3-5份、冰片1-2份、鹅不食草3-5份、白芷1-2份、儿茶3-5份、川芎1-2份、栀子1-2份,以及羟丙基甲基纤维素2-3份。
3.根据权利要求2所述的精油组合物,包括如下重量份的原料:桃金娘油32份、辛夷花油8份、薄荷精油4份、冰片1.5份、鹅不食草4份、白芷1.5份、儿茶4份、川芎1.5份、栀子1.5份,以及羟丙基甲基纤维素2份。
4.根据权利要求1-3任一项所述的治疗鼻窦炎的精油组合物的制备方法,其特征在于,包括如下步骤:
(1)按重量份比称取桃金娘油、辛夷花油和薄荷精油,置于无菌反应釜中,灭菌处理;
(2)按重量份比称取冰片、白芷、羟丙基甲基纤维素,研磨,过筛网即得研磨粉;
(3)按重量份比称取鹅不食草、儿茶、川芎和栀子,投入反应釜中,加入蒸馏水浸泡一段时间,破壁打浆,煮沸后改用小火煎煮,滤出一次煎煮液,再次加入蒸馏水煎煮,煮沸后改用小火煎煮,滤出二次煎煮液;将一次、二次滤液混合均匀、冷却、过滤,取滤液,将滤液浓缩至所需重量,即得中药提取液;
(4)将(2)和(3)的产物混合均匀后灭菌处理;
(5)将(1)和(4)的产物混合,即得疗鼻窦炎的精油组合物。
5.根据权利要求4所述的治疗鼻窦炎的精油组合物的制备方法,其特征在于,步骤(2)为过100目筛网。
6.根据权利要求4所述的治疗鼻窦炎的精油组合物的制备方法,其特征在于,步骤(3),按重量份比称取鹅不食草、儿茶、川芎和栀子,投入反应釜中,加入200份蒸馏水浸泡一段时间,破壁打浆,煮沸后改用小火煎煮30min,滤出一次煎煮液,再次加入100份蒸馏水煎煮,煮沸后改用小火煎煮30min,滤出二次煎煮液;将一次、二次滤液混合均匀、冷却、过滤,取滤液,将滤液浓缩至所需重量,即得中药提取液。
7.一种权利要求1-3任一项所述的治疗鼻窦炎的精油组合物的使用方法:将所述精油组合物涂抹于鼻腔表面,外敷温热毛巾,至精油被完全吸收即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111463776.3A CN113925901A (zh) | 2021-12-03 | 2021-12-03 | 一种治疗鼻窦炎的精油组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111463776.3A CN113925901A (zh) | 2021-12-03 | 2021-12-03 | 一种治疗鼻窦炎的精油组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113925901A true CN113925901A (zh) | 2022-01-14 |
Family
ID=79288698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111463776.3A Pending CN113925901A (zh) | 2021-12-03 | 2021-12-03 | 一种治疗鼻窦炎的精油组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113925901A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115449422A (zh) * | 2022-09-14 | 2022-12-09 | 杭州香芝生物科技有限公司 | 一种萃取辛夷花油的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102247438A (zh) * | 2010-05-18 | 2011-11-23 | 马赛香 | 一种通鼻窍的闻药 |
CN105434618A (zh) * | 2015-12-08 | 2016-03-30 | 王龙 | 新型中药通窍鼻炎药物及其使用方法 |
CN105535107A (zh) * | 2016-01-25 | 2016-05-04 | 史沛现 | 一种治疗鼻咽炎的药物组合物及其制备方法 |
CN106265966A (zh) * | 2016-10-21 | 2017-01-04 | 张有强 | 一种治疗鼻窦炎、过敏性鼻炎、鼻甲肥大的中药 |
CN107412530A (zh) * | 2017-08-07 | 2017-12-01 | 李亚彬 | 一种治疗鼻炎的药膏及其制备方法 |
-
2021
- 2021-12-03 CN CN202111463776.3A patent/CN113925901A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102247438A (zh) * | 2010-05-18 | 2011-11-23 | 马赛香 | 一种通鼻窍的闻药 |
CN105434618A (zh) * | 2015-12-08 | 2016-03-30 | 王龙 | 新型中药通窍鼻炎药物及其使用方法 |
CN105535107A (zh) * | 2016-01-25 | 2016-05-04 | 史沛现 | 一种治疗鼻咽炎的药物组合物及其制备方法 |
CN106265966A (zh) * | 2016-10-21 | 2017-01-04 | 张有强 | 一种治疗鼻窦炎、过敏性鼻炎、鼻甲肥大的中药 |
CN107412530A (zh) * | 2017-08-07 | 2017-12-01 | 李亚彬 | 一种治疗鼻炎的药膏及其制备方法 |
Non-Patent Citations (3)
Title |
---|
喻维新等: "《药师手册(第4版)》", 31 July 2019, 中国医药科技出版社 * |
李航等: "标准桃金娘油的临床应用进展", 《中国药业》 * |
王良信: "《中医高效偏方验方4000首》", 30 June 2015, 中国医药科技出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115449422A (zh) * | 2022-09-14 | 2022-12-09 | 杭州香芝生物科技有限公司 | 一种萃取辛夷花油的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102772591B (zh) | 一种治疗鼻炎的中空、通气、双层中药栓剂及其制作方法 | |
CN103877429B (zh) | 一种治疗鼻窦炎的中药制剂及制备方法 | |
CN104096141A (zh) | 一种治疗过敏性结膜炎的中药组合物 | |
CN113925901A (zh) | 一种治疗鼻窦炎的精油组合物及其制备方法 | |
CN105535196A (zh) | 一种用于治疗鼻炎的药物组合物及其制备方法 | |
CN105012585A (zh) | 一种治疗鼻炎的中药 | |
CN102068527A (zh) | 一种根除青春痘的药物及治疗方法 | |
CN116115689A (zh) | 七窍通鼻炎喷剂及其制备方法 | |
CN104958581A (zh) | 一种用于治疗毛囊炎的中药制剂及制备方法 | |
CN113713011A (zh) | 一种治疗鼻炎的中药组合物及其制备方法 | |
CN111759887A (zh) | 一种鼻炎膏及其制备方法 | |
CN112972578A (zh) | 一种治疗牛皮癣的膏剂及其制备方法 | |
CN105327103A (zh) | 一种治疗鼻炎、鼻窦炎的药物组合物及其制备方法 | |
CN108114220A (zh) | 一种治疗鼻炎的胶囊剂药物及制备方法 | |
CN110013520B (zh) | 治疗黄褐斑的药物组合物 | |
CN108186960B (zh) | 一种治疗咽炎的中药及其制备方法 | |
CN104523850A (zh) | 一种治疗鼻炎、鼻窦炎的药物组合物 | |
CN110755531A (zh) | 治疗鼻炎的中药组合物及其外用涂抹式凝胶 | |
CN112807373A (zh) | 一种用于儿童慢性鼻炎的中药组合物及其制备方法 | |
CN104606447A (zh) | 一种治疗外感发热的中药制剂 | |
CN105055676A (zh) | 一种地锦草口服液 | |
CN104997949A (zh) | 一种治疗鼻炎的中药组合物及其制备方法 | |
CN113599418A (zh) | 一种治疗鼻炎的中药制剂及其制备方法 | |
CN104800658A (zh) | 治疗鼻窦炎的中药制剂 | |
CN113925895A (zh) | 一种治疗急慢性鼻炎的中药组合物、口服制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |